Clinical Research News
-
WCG introduces a transformational solution for clinical research sites
Clinical Research | News | 0 Comment | 20 Mar, 2019
WIRB-Copernicus Group has introduced WCG SiteReady, a first-of-its-kind solution aimed at increasing the efficiency and profitability of clinical research for institutions and independent r...Read more
-
Clinical Research | News | 0 Comment | 18 Mar, 2019
ImmunogenX has announced the initiation of a Phase 2 clinical trial (named Celiac Shield), sponsored by the National Institutes of Health’s (NIH) National Center for Complementar...Read more
-
Clinical Research | News | 0 Comment | 15 Mar, 2019
Bayer presented results from the CHICO part (CHagas disease In Children treated with NifurtimOx) of the phase III clinical study of investigational nifurtimox in pediatric patients with Cha...Read more
-
Alvotech enrolls first patient for Ph III study involving Biosimilar version of HUMIRA
Clinical Research | News | 0 Comment | 14 Mar, 2019
Global biopharmaceutical company Alvotech has announced that it has enrolled the first patient in its Phase III clinical study (ALVOPAD PS) involving AVT02, Alvotech's HUMIRA biosimilar can...Read more
-
Kezar Life Sciences to test a new drug formulation of KZR-616
Clinical Research | News | 0 Comment | 07 Mar, 2019
Kezar Life Sciences, a South San Francisco-based clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity...Read more
-
Dr Albers receives the distinguished Clinical Research Achievement Award for stroke research
Clinical Research | News | 0 Comment | 07 Mar, 2019
iSchemaView, the worldwide leader in advanced imaging for stroke care and research, is proud to announce that iSchemaView co-founder Dr. Gregory Albers has received the highly respected Dis...Read more
-
Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial
Clinical Research | News | 0 Comment | 25 Feb, 2019
Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs and a pioneer in gene regulatory and immunotherapeutic drugs utiliz...Read more
-
Foresee Pharma announces topline results of FP-001 LMIS in prostate cancer
Clinical Research | News | 0 Comment | 22 Feb, 2019
Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange has announced that the topline results of FP-001 LMIS (Leuprolide Mesylate Injectable ...Read more
-
Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study
Clinical Research | News | 0 Comment | 22 Feb, 2019
Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing new drugs and APIs (Active Pharmaceutical Ingredients) has announced...Read more
-
Owlstone Medical partners with Shanghai Renji Hospital
Clinical Research | News | 0 Comment | 25 Feb, 2019
Owlstone Medical, a diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Renji Hospital have announced a collaboration to co...Read more
-
Sosei Heptares initiates new clinical development programme
Clinical Research | News | 0 Comment | 22 Feb, 2019
Sosei Group Corporation, has announced that the first healthy subject has been dosed with a novel small molecule HTL0030310 in a Phase I clinical study, marking the start of a new in-house ...Read more
-
Mallinckrodt presents analysis results for Therakos against aGvHD
Clinical Research | News | 0 Comment | 21 Feb, 2019
Mallinckrodt plc, a leading global specialty pharmaceutical company has announced interim analysis results of its company-sponsored, Phase 3, single-arm, open-label, multi-center study asse...Read more
-
Saniona announces succesful completion of preclinical development of SAN711
Clinical Research | News | 0 Comment | 19 Feb, 2019
Saniona, a biotech company focused on CNS and eating disorders has announced the successful completion of preclinical development of SAN711, for the treatment of chronic itching and neuropa...Read more
-
Navitas Life Sciences acquires DataCeutics in a $45 MM deal
Clinical Research | News | 0 Comment | 14 Feb, 2019
Navitas Life Sciences, a TAKE Solutions Enterprise has announced that it will be acquiring Life Sciences services player, DataCeutics in North America. The acquisition, as part of the 2021...Read more
-
Boehringer Ingelheim, IBM to integrate blockchain tech in clinical trials
Clinical Research | News | 0 Comment | 14 Feb, 2019
Boehringer Ingelheim (Canada) Ltd. and IBM Canada have announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore ...Read more
-
Pfizer, Astellas announce results from Ph 3 ARCHES trial in men with mHSPC
Clinical Research | News | 0 Comment | 12 Feb, 2019
Pfizer Inc. and Astellas Pharma Inc. have announced the results from the Phase 3 ARCHES trial in men with metastatic hormone-sensitive prostate cancer (mHSPC). Prostate cancer is considered...Read more
-
“An efficient approach to clinical trial design will have the greatest impact”
Clinical Research | Opinion | 0 Comment | 06 Feb, 2019
The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies defining the healthcare industry. This is the largest and most informative h...Read more
-
TLC appoints George Spencer-Green as CMO
Clinical Research | News | 0 Comment | 05 Feb, 2019
Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of unmet medica...Read more
